Related references
Note: Only part of the references are listed.Prescription Opioid Use Among Patients With Acute Gout Discharged From the Emergency Department
Deepan S. Dalal et al.
ARTHRITIS CARE & RESEARCH (2020)
Response to the 2020 American College of Rheumatology Guideline for the Management of Gout: Comment on the Article by FitzGerald et al
Peter E. Lipsky et al.
ARTHRITIS CARE & RESEARCH (2020)
Opioid Utilization and Perception of Pain Control in Hospitalized Patients: A Cross-Sectional Study of 11 Sites in 8 Countries
Marisha Burden et al.
JOURNAL OF HOSPITAL MEDICINE (2019)
Factors associated with commencing and ceasing opioid therapy in patients with rheumatoid arthritis
Rachel J. Black et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)
Adherence and Outcomes with Urate-Lowering Therapy: A Site-Randomized Trial
Ted R. Mikuls et al.
AMERICAN JOURNAL OF MEDICINE (2019)
Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007-2016
Michael Chen-Xu et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Design and Rationale for the Veterans Affairs Cooperative Study Program 594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat Trial
S. Timilsina et al.
CONTEMPORARY CLINICAL TRIALS (2018)
Prescription pattern of urate-lowering therapy in Korean gout patients: data from the national health claims database
Ji-Won Kim et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2018)
Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial
Michael Doherty et al.
LANCET (2018)
Work disability in gout: a population-based case-control study
Valgerdur Sigurdardottir et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Management of Acute and Recurrent Gout: A Clinical Practice Guideline From the American College of Physicians
Amir Qaseem et al.
ANNALS OF INTERNAL MEDICINE (2017)
2016 updated EULAR evidence-based recommendations for the management of gout
P. Richette et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Epidemiology of inpatient gout in Australia and New Zealand: temporal trends, comorbidities and gout flare site
Philip C. Robinson et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2017)
Arthritis, comorbidities, and care utilization in veterans of operations enduring and Iraqi Freedom
Jessica C. Rivera et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2017)
Allopurinol Medication Adherence as a Mediator of Optimal Outcomes in Gout Management
Brian W. Coburn et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2017)
Opioid-Prescribing Patterns of Emergency Physicians and Risk of Long-Term Use
Michael L. Barnett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Prevalence and incidence of gout in Korea: data from the national health claims database 2007-2015
Ji-Won Kim et al.
RHEUMATOLOGY INTERNATIONAL (2017)
The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012
Sharan K. Rai et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
Performance of gout definitions for genetic epidemiological studies: analysis of UK Biobank
Murray Cadzow et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Health care utilization in patients with gout: a prospective multicenter cohort study
Jasvinder A. Singh et al.
BMC MUSCULOSKELETAL DISORDERS (2017)
Time Trends, Predictors, and Outcome of Emergency Department Use for Gout: A Nationwide US Study
Jasvinder A. Singh et al.
JOURNAL OF RHEUMATOLOGY (2016)
Independent impact of gout on the risk of diabetes mellitus among women and men: a population-based, BMI-matched cohort study
Young Hee Rho et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Incidence and prevalence of gout in Western Sweden
Mats Dehlin et al.
ARTHRITIS RESEARCH & THERAPY (2016)
The economic burden of gout: A systematic review
Sharan K. Rai et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Validation of the Rheumatic Disease Comorbidity Index
Bryant R. England et al.
ARTHRITIS CARE & RESEARCH (2015)
Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies
Matthew J. Roughley et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Epidemiology and management of gout in Taiwan: a nationwide population study
Chang-Fu Kuo et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study
Chang-Fu Kuo et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Eligibility for and Prescription of Urate-Lowering Treatment in Patients With Incident Gout in England
Chang-Fu Kuo et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Gout-Related Health Care Utilization in US Emergency Departments, 2006 Through 2008
Rohini Garg et al.
ARTHRITIS CARE & RESEARCH (2013)
Hepatitis C Virus Screening and Prevalence Among US Veterans in Department of Veterans Affairs Care
Lisa I. Backus et al.
JAMA INTERNAL MEDICINE (2013)
Initiation of Allopurinol at First Medical Contact for Acute Attacks of Gout: A Randomized Clinical Trial
Thomas H. Taylor et al.
AMERICAN JOURNAL OF MEDICINE (2012)
Systematic review of the prevalence of gout and hyperuricaemia in Australia
P. C. Robinson et al.
INTERNAL MEDICINE JOURNAL (2012)
2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
Dinesh Khanna et al.
ARTHRITIS CARE & RESEARCH (2012)
Comorbidity Burden, Healthcare Resource Utilization, and Costs in Chronic Gout Patients Refractory to Conventional Urate-Lowering Therapy
Eric Q. Wu et al.
AMERICAN JOURNAL OF THERAPEUTICS (2011)
Prevalence of Gout and Hyperuricemia in the US General Population The National Health and Nutrition Examination Survey 2007-2008
Yanyan Zhu et al.
ARTHRITIS AND RHEUMATISM (2011)
Which chronic diseases and disease combinations are specific to multimorbidity in the elderly? Results of a claims data based cross-sectional study in Germany
Hendrik van den Bussche et al.
BMC PUBLIC HEALTH (2011)
Reliability and Sensitivity of the Self-report of Physician-diagnosed Gout in the Campaign Against Cancer and Heart Disease and the Atherosclerosis Risk in the Community Cohorts
Mara A. McAdams et al.
JOURNAL OF RHEUMATOLOGY (2011)
Disease-related and all-cause health care costs of elderly patients with gout
Eric Q. Wu et al.
JOURNAL OF MANAGED CARE PHARMACY (2008)
Independent impact of gout on mortality and risk for coronary heart disease
Hyon K. Choi et al.
CIRCULATION (2007)
Validity of gout diagnoses in administrative data
Leslie R. Harrold et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Prevalence of the metabolic syndrome in patients with gout: The Third National Health and Nutrition Examination Survey
Hyon K. Choi et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Prevalence and costs of chronic conditions in the VA health care system
W Yu et al.
MEDICAL CARE RESEARCH AND REVIEW (2003)